Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis
Yvonne A. Evrard,
Carol J Bult,
James H. Doroshow,
Min Jin Ha,
Michael T Lewis,
Jeffrey A Moscow,
Peter N Robinson,
Brian A. Van Tine,
Alana L Welm,
Bryan E. Welm,
Dennis A. Dean,
Jeffrey S Morris,
Jeffrey H. Chuang
Posted 02 Oct 2019
bioRxiv DOI: 10.1101/790246 (published DOI: 10.1158/0008-5472.CAN-19-3101)
Posted 02 Oct 2019
Patient-Derived Xenografts (PDXs) are tumor-in-mouse models for cancer. PDX collections, such as those supported by the NCI PDXNet program, are powerful resources for preclinical therapeutic testing. However, variations in experimental design and analysis procedures have limited interpretability. To determine the robustness of PDX studies, the PDXNet tested temozolomide drug response for three pre-validated PDX models (sensitive, resistant, and intermediate) across four blinded PDX Development and Trial Centers (PDTCs) using independently selected SOPs. Each PDTC was able to correctly identify the sensitive, resistant, and intermediate models, and statistical evaluations were concordant across all groups. We also developed and benchmarked optimized PDX informatics pipelines, and these yielded robust assessments across xenograft biological replicates. These studies show that PDX drug responses and sequence results are reproducible across diverse experimental protocols. Here we share the range of experimental procedures that maintained robustness, as well as standardized cloud-based workflows for PDX exome-seq and RNA-Seq analysis and for evaluating growth.
- Downloaded 535 times
- Download rankings, all-time:
- Site-wide: 69,871
- In cancer biology: 2,017
- Year to date:
- Site-wide: 114,510
- Since beginning of last month:
- Site-wide: 132,142
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!